Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 3/20 | 0.42 |
| ▸ | FABP7 | O15540 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | TLR2 | O60603 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23924622 | 0.99 | FABP5 (0.41) | FABP5FABP7KMT2ASLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL30020146 | 0.99 | FABP5 (0.41) | FABP5FABP7KMT2ASLC6A2SLC6A4 | |
| SCHEMBL25797253 | 0.88 | KMT2A (0.41) | FABP5FABP7KMT2ASLC6A2SLC6A4 | |
| SCHEMBL23930395 | 0.83 | FABP5 (0.40) | FABP5FABP7KMT2AEPHX2OPRD1 | |
| SCHEMBL11902048 | 0.80 | KMT2A (0.45) | FABP5FABP7KMT2AEPHX2OPRD1 | |
| SCHEMBL30408826 | 0.79 | FABP5 (0.40) | FABP5FABP7KMT2ACHRM3EPHX2 | |
| SCHEMBL23924702 | 0.78 | NAMPT (0.41) | — | |
| SCHEMBL30267608 | 0.78 | NAMPT (0.41) | — | |
| SCHEMBL25224718 | 0.78 | KMT2A (0.39) | FABP5FABP7KMT2ASLC6A2SLC6A4 | |
| SCHEMBL2039581 | 0.77 | KMT2A (0.42) | FABP5FABP7KMT2AEPHX2OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691964-B2 | Crystalline forms of phthalazinone compound | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11691964-B2 | Crystalline forms of phthalazinone compound | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-20210323945-A1 | CRYSTALLINE FORMS OF PHTHALAZINONE COMPOUND | IDIENCE CO., LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
| US-20210323946-A1 | PROCESS FOR PREPARING A PHTHALAZINONE DERIVATIVE AND INTERMEDIATES THEREOF | IDIENCE CO., LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323945-A1 | CRYSTALLINE FORMS OF PHTHALAZINONE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RCC1, UACA | FABP5 1225/4885FABP7 3049/4885KMT2A 712/4885 |
| US-11691964-B2 | Crystalline forms of phthalazinone compound | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RCC1, UACA | FABP5 1225/4885FABP7 3049/4885KMT2A 712/4885 |
| US-20210323946-A1 | PROCESS FOR PREPARING A PHTHALAZINONE DERIVATIVE AND INTERMEDIATES THEREOF | NISCH, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DHPS | FABP5 3528/4885FABP7 3978/4885KMT2A 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.